| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $46.0M | +92.2% |
| SG&A Expense | $21.1M | +142.1% |
| Operating Income | -$67.1M | -105.5% |
| Net Income | -$60.4M | -93.8% |
| EPS (Basic) | -$2.74 | +63.8% |
| EPS (Diluted) | -$2.74 | +63.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $36.0M | +22.0% |
| Short-term Investments | $91.4M | -6.9% |
| Current Assets | $129.7M | -1.8% |
| Total Assets | $138.3M | -23.7% |
| Current Liabilities | $13.3M | +104.2% |
| Total Liabilities | $17.1M | +58.8% |
| Stockholders' Equity | $121.2M | -28.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$42.6M | -41.6% |
| Capital Expenditures | $1.3M | -40.5% |
| Investing Cash Flow | $50.7M | +135.8% |
| Financing Cash Flow | -$1.6M | -101.5% |
| Free Cash Flow | -$43.9M | -36.1% |